Patents by Inventor Danny Bruce

Danny Bruce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11471517
    Abstract: ILC2 cells play a role in the pathogenesis of graft versus host disease (GvHD) and idiopathic pneumonia syndrome (IPS), both conditions associated with allogeneic stem cell transplantation. Infusion of IL-33 activated ILC2 cells into patients with ongoing GvHD or IPS, or prior to onset of GvHD or IPS in susceptible patients, substantially ameliorates the disease and improves survival.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: October 18, 2022
    Assignees: The University of North Carolina at Chapel Hill, Regents of the University of Minnesota
    Inventors: Jonathan Serody, James Coghill, Danny Bruce, Bruce Blazar, Heather Stefanski, Benjamin Vincent
  • Patent number: 10820977
    Abstract: A system and method of administrating conventional hyperbaric chamber therapy as well as supplemental oxygen therapy at ambient conditions to an animal using a veterinary hyperbaric chamber. The hyperbaric chamber can function in its usual mode of operation; i.e., providing oxygen at greater than atmospheric pressure and also in a second mode of operation to administer supplemental oxygen thereafter at ambient pressure conditions. In the second mode of operation, the method and apparatus may deliver approximately 80 liters per minute continuous flow of 0.21 through 1.0 FI02 adjustable oxygen gas mixture. The mixture is delivered at ambient pressure from one end of the chamber, flows across the animal positioned within the hyperbaric chamber, and exits at the opposite end for exhaust to ambient conditions. A high flow gas mixture is utilized to maintain accurate gas mixture concentrations with fluctuating supply pressures of medical air and medical oxygen gases.
    Type: Grant
    Filed: July 26, 2017
    Date of Patent: November 3, 2020
    Assignee: Sechrist Industries, Inc.
    Inventors: Deepak Ambalal Talati, Danny Bruce Hudson, Teofilo Raymund G. Tan, III, Ronald Lyman
  • Publication number: 20200155656
    Abstract: ILC2 cells play a role in the pathogenesis of graft versus host disease (GvHD) and idiopathic pneumonia syndrome (IPS), both conditions associated with allogeneic stem cell transplantation. Infusion of IL-33 activated ILC2 cells into patients with ongoing GvHD or IPS, or prior to onset of GvHD or IPS in susceptible patients, substantially ameliorates the disease and improves survival.
    Type: Application
    Filed: October 10, 2019
    Publication date: May 21, 2020
    Inventors: Jonathan Serody, James Coghill, Danny Bruce, Bruce Blazar, Heather Stefanski, Benjamin Vincent
  • Publication number: 20180028299
    Abstract: A system and method of administrating conventional hyperbaric chamber therapy as well as supplemental oxygen therapy at ambient conditions to an animal using a veterinary hyperbaric chamber. The hyperbaric chamber can function in its usual mode of operation; i.e., providing oxygen at greater than atmospheric pressure and also in a second mode of operation to administer supplemental oxygen thereafter at ambient pressure conditions. In the second mode of operation, the method and apparatus may deliver approximately 80 liters per minute continuous flow of 0.21 through 1.0 FI02 adjustable oxygen gas mixture. The mixture is delivered at ambient pressure from one end of the chamber, flows across the animal positioned within the hyperbaric chamber, and exits at the opposite end for exhaust to ambient conditions. A high flow gas mixture is utilized to maintain accurate gas mixture concentrations with fluctuating supply pressures of medical air and medical oxygen gases.
    Type: Application
    Filed: July 26, 2017
    Publication date: February 1, 2018
    Inventors: Deepak Ambalal Talati, Danny Bruce Hudson, Teofilo Raymund G. Tan, III, Ronald Lyman
  • Publication number: 20170360907
    Abstract: ILC2 cells play a role in the pathogenesis of graft versus host disease (GvHD) and idiopathic pneumonia syndrome (IPS), both conditions associated with allogeneic stem cell transplantation. Infusion of IL-33 activated ILC2 cells into patients with ongoing GvHD or IPS, or prior to onset of GvHD or IPS in susceptible patients, substantially ameliorates the disease and improves survival.
    Type: Application
    Filed: December 4, 2015
    Publication date: December 21, 2017
    Inventors: Jonathan Serody, James Coghill, Danny Bruce, Bruce Blazar, Heather Stefanski, Benjamin Vincent
  • Patent number: 7191552
    Abstract: A footwear sole for providing firmness and support to the lateral edge of a person's foot. The footwear sole includes a plurality of layers of material including a first layer of material having a definite thickness and also including a second layer of material also having a definite thickness with the second layer of material being softer than the first layer of material.
    Type: Grant
    Filed: March 8, 2005
    Date of Patent: March 20, 2007
    Inventor: Danny Bruce Husom
  • Patent number: D727510
    Type: Grant
    Filed: August 30, 2012
    Date of Patent: April 21, 2015
    Assignee: Sechrist Industries, Inc.
    Inventors: Deepak Ambalal Talati, Danny Bruce Hudson, Teofilo Raymund G. Tan, III